Factors Associated With Insulin Resistance in Adults With HIV Receiving Contemporary Antiretroviral Therapy: a Brief Update
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Factors Associated With Insulin Resistance in Adults With HIV Receiving Contemporary Antiretroviral Therapy: a Brief Update
Authors
Keywords
HIV, Antiretroviral therapy, Insulin resistance, Hyperglycemia, Integrase inhibitors
Journal
Current HIV/AIDS Reports
Volume 15, Issue 3, Pages 223-232
Publisher
Springer Nature
Online
2018-04-26
DOI
10.1007/s11904-018-0399-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Contemporary protease inhibitors and cardiovascular risk
- (2018) Jens Lundgren et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Incidence and Risk Factors for Prediabetes and Diabetes Mellitus Among HIV-infected Adults on Antiretroviral Therapy
- (2018) Jobert Richie Nansseu et al. EPIDEMIOLOGY
- Whole-Body Imaging of Tissue-specific Insulin Sensitivity and Body Composition by Using an Integrated PET/MR System: A Feasibility Study
- (2018) Emil Johansson et al. RADIOLOGY
- Impact of circulating bacterial DNA in long-term glucose homeostasis in non-diabetic patients with HIV infection: cohort study
- (2017) Ó. Moreno-Pérez et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Evaluation of the concurrent use of dolutegravir and metformin in human immunodeficiency virus-infected patients
- (2017) Anne Masich et al. INTERNATIONAL JOURNAL OF STD & AIDS
- Brief Report
- (2017) Jamison Norwood et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Dolutegravir-induced hyperglycaemia in a patient living with HIV
- (2017) Milena McLaughlin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial
- (2017) Paul E Sax et al. LANCET
- Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial
- (2017) Joel Gallant et al. LANCET
- Statin use and risk of new-onset diabetes: A meta-analysis of observational studies
- (2017) M. Casula et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- HIV and its relationship to insulin resistance and lipid abnormalities
- (2017) Lemuel R. Non et al. Translational Research
- The Fat of the Matter: Obesity and Visceral Adiposity in Treated HIV Infection
- (2017) Jordan E. Lake Current HIV/AIDS Reports
- Bictegravir versus dolutegravir, each with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection: a randomised, double-blind, phase 2 trial
- (2017) Paul E Sax et al. Lancet HIV
- Comparison of Insulin Resistance to Coronary Atherosclerosis in Human Immunodeficiency Virus Infected and Uninfected Men (from the Multicenter AIDS Cohort Study)
- (2016) Michael I. Brener et al. AMERICAN JOURNAL OF CARDIOLOGY
- Impact of elvitegravir on human adipocytes: Alterations in differentiation, gene expression and release of adipokines and cytokines
- (2016) Ricardo Moure et al. ANTIVIRAL RESEARCH
- Neither boosted elvitegravir nor darunavir with emtricitabine/tenofovir disoproxil fumarate increase insulin resistance in healthy volunteers: results from the STRIBILD-IR study
- (2016) Christoph D Spinner et al. ANTIVIRAL THERAPY
- Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s
- (2016) Grace A. McComsey et al. CLINICAL INFECTIOUS DISEASES
- Effects of once-daily darunavir/ritonavir versus atazanavir/ritonavir on insulin sensitivity in HIV-infected persons over 48 weeks: results of an exploratory substudy of METABOLIK, a phase 4, randomized trial
- (2016) Edgar Turner Overton et al. HIV CLINICAL TRIALS
- Integrase strand transfer inhibitor-associated diabetes mellitus: A case report
- (2016) Peter S Fong et al. INTERNATIONAL JOURNAL OF STD & AIDS
- The Effect of Dolutegravir on the Pharmacokinetics of Metformin in Healthy Subjects
- (2016) Ivy H. Song et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Impaired lipid profile and insulin resistance in a cohort of Austrian HIV patients
- (2016) Kathrin Schulte-Hermann et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Immunologic Biomarkers, Morbidity, and Mortality in Treated HIV Infection
- (2016) Peter W. Hunt et al. JOURNAL OF INFECTIOUS DISEASES
- Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infection
- (2016) Camilla Tincati et al. AIDS Research and Therapy
- Genetics of Insulin Resistance and the Metabolic Syndrome
- (2016) Audrey E. Brown et al. Current Cardiology Reports
- Metabolic Complications and Glucose Metabolism in HIV Infection: A Review of the Evidence
- (2016) Amanda L. Willig et al. Current HIV/AIDS Reports
- Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s
- (2016) Sahera Dirajlal-Fargo et al. Open Forum Infectious Diseases
- Physical Activity and Its Association with Insulin Resistance in Multicenter AIDS Cohort Study Men
- (2015) Anne K. Monroe et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Lipid and glucose alterations in perinatally-acquired HIV-infected adolescents and young adults
- (2015) Daniel Blázquez et al. BMC INFECTIOUS DISEASES
- Rosuvastatin Worsens Insulin Resistance in HIV-Infected Adults on Antiretroviral Therapy
- (2015) Kristine M. Erlandson et al. CLINICAL INFECTIOUS DISEASES
- Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention
- (2015) Ulrike Hostalek et al. DRUGS
- RAAS Activation Is Associated With Visceral Adiposity and Insulin Resistance Among HIV-infected Patients
- (2015) Suman Srinivasa et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Human immunodeficiency virus (HIV) modulates the associations between insulin resistance and cognition in the current combination antiretroviral therapy (cART) era: a study of the Women’s Interagency HIV Study (WIHS)
- (2015) Victor Valcour et al. JOURNAL OF NEUROVIROLOGY
- High Prevalence of Dyslipidemia and Insulin Resistance in HIV-Infected Pre-Pubertal African Children on Antiretroviral Therapy
- (2015) Steve Innes et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Impact of randomized antiretroviral therapy initiation on glucose metabolism
- (2014) Kristine Mace Erlandson et al. AIDS
- Ectopic Fat, Insulin Resistance, and Nonalcoholic Fatty Liver Disease
- (2014) Christopher D. Byrne et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- FTOrs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients
- (2014) Daniel Pineda-Tenor et al. BMC Medicine
- Surrogate measures of insulin sensitivity vs the hyperinsulinaemic–euglycaemic clamp: a meta-analysis
- (2014) Julia Otten et al. DIABETOLOGIA
- The good and bad effects of statins on insulin sensitivity and secretion
- (2014) Giovanna Muscogiuri et al. ENDOCRINE RESEARCH
- Prevalence of insulin resistance and risk of diabetes mellitus in HIV-infected patients receiving current antiretroviral drugs
- (2014) Susana Araujo et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study
- (2014) A. Castagna et al. JOURNAL OF INFECTIOUS DISEASES
- Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
- (2014) Gerald I. Shulman NEW ENGLAND JOURNAL OF MEDICINE
- Monocytes Expand with Immune Dysregulation and Is Associated with Insulin Resistance in Older Individuals with Chronic HIV
- (2014) Cecilia M. Shikuma et al. PLoS One
- Mitochondrial DNA Variation and Changes in Adiponectin and Endothelial Function in HIV-Infected Adults After Antiretroviral Therapy Initiation
- (2013) Todd Hulgan et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Pilot Study of Pioglitazone and Exercise Training Effects on Basal Myocardial Substrate Metabolism and Left Ventricular Function in HIV-Positive Individuals with Metabolic Complications
- (2013) W. Todd Cade et al. HIV CLINICAL TRIALS
- Microbial Translocation in HIV Infection Is Associated With Dyslipidemia, Insulin Resistance, and Risk of Myocardial Infarction
- (2013) Karin K. Pedersen et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Dynamic PET Imaging Reveals Heterogeneity of Skeletal Muscle Insulin Resistance
- (2013) Jason M. Ng et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Adipose Tissue and Immune Function: A Review of Evidence Relevant to HIV Infection
- (2013) John R. Koethe et al. JOURNAL OF INFECTIOUS DISEASES
- Evidence for Innate Immune System Activation in HIV Type 1–Infected Elite Controllers
- (2013) Sonya Krishnan et al. JOURNAL OF INFECTIOUS DISEASES
- IL28RApolymorphism (rs10903035) is associated with insulin resistance in HIV/HCV-coinfected patients
- (2013) M. A. Jiménez-Sousa et al. JOURNAL OF VIRAL HEPATITIS
- Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study
- (2013) Francois Raffi et al. LANCET
- Metabolic disease in HIV infection
- (2013) Jordan E Lake et al. LANCET INFECTIOUS DISEASES
- Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection
- (2013) Sharon L. Walmsley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insulin Resistance and Glucose and Lipid Concentrations in a Cohort of Perinatally HIV-infected Latin American Children
- (2013) Rohan Hazra et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- The Association Between Diet and Physical Activity on Insulin Resistance in the Womenʼs Interagency HIV Study
- (2012) Nancy A. Hessol et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Changes in Fat Mitochondrial DNA and Function in Subjects Randomized to Abacavir-Lamivudine or Tenofovir DF–Emtricitabine With Atazanavir-Ritonavir or Efavirenz: AIDS Clinical Trials Group Study A5224s, Substudy of A5202
- (2012) Grace A. McComsey et al. JOURNAL OF INFECTIOUS DISEASES
- Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks
- (2012) Paul E Sax et al. LANCET
- Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial
- (2012) Edwin DeJesus et al. LANCET
- Adaptive immunity in obesity and insulin resistance
- (2012) Henrike Sell et al. Nature Reviews Endocrinology
- Microbial translocation, immune activation, and HIV disease
- (2012) Nichole R. Klatt et al. TRENDS IN MICROBIOLOGY
- Insulin resistance in treated HIV infection
- (2011) E.R. Feeney et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects
- (2011) Markella V. Zanni et al. CLINICAL ENDOCRINOLOGY
- Peripheral and Central Fat Changes in Subjects Randomized to Abacavir-Lamivudine or Tenofovir-Emtricitabine With Atazanavir-Ritonavir or Efavirenz: ACTG Study A5224s
- (2011) G. A. McComsey et al. CLINICAL INFECTIOUS DISEASES
- Neutral Actions of Raltegravir on Adipogenesis, Glucose Metabolism and Lipolysis in 3T3-L1 Adipocytes
- (2011) Patricia Perez-Matute et al. CURRENT HIV RESEARCH
- European Mitochondrial DNA Haplogroups and Metabolic Disorders in HIV/HCV-Coinfected Patients on Highly Active Antiretroviral Therapy
- (2011) Dariela Micheloud et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Effect of boosted fosamprenavir or lopinavir-based combinations on whole-body insulin sensitivity and lipids in treatment-naive HIV-type-1-positive men
- (2010) Paul A Randell et al. ANTIVIRAL THERAPY
- Adipose Tissue and Metabolic Factors Associated With Steatosis in HIV/HCV Coinfection: Histology Versus Magnetic Resonance Spectroscopy
- (2010) Alireza Ghotb et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Comparison of the influence of four classes of HIV antiretrovirals on adipogenic differentiation: the minimal effect of raltegravir and atazanavir
- (2010) Rumi Minami et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Evaluation of glucose uptake by skeletal muscle tissue and subcutaneous fat in HIV-infected patients with and without lipodystrophy using FDG-PET
- (2010) Mike Sathekge et al. NUCLEAR MEDICINE COMMUNICATIONS
- Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment
- (2009) Richard H Haubrich et al. AIDS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation